Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1987-11-17
pubmed:abstractText
Histamine-induced skin reactions were studied in four animal species. Cetirizine displayed very potent oral antihistaminic activity in this model. In rats, the dose that reduced the reaction by 50% in comparison to controls was 4.2 mumol/kg and between 0.1 and 0.4 mumol/kg for the other species (mice, guinea pigs, and dogs). Cetirizine also inhibited the immediate hypersensitivity reaction induced by Ascaris extract in dogs. By the oral route, cetirizine had a more potent and longer acting activity than mepyramine, clemastine, terfenadine, astemizole, and hydroxyzine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0003-4738
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
278-82
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:2959177-Allergens, pubmed-meshheading:2959177-Animals, pubmed-meshheading:2959177-Benzhydryl Compounds, pubmed-meshheading:2959177-Cetirizine, pubmed-meshheading:2959177-Clemastine, pubmed-meshheading:2959177-Dogs, pubmed-meshheading:2959177-Female, pubmed-meshheading:2959177-Guinea Pigs, pubmed-meshheading:2959177-Histamine, pubmed-meshheading:2959177-Histamine Antagonists, pubmed-meshheading:2959177-Hydroxyzine, pubmed-meshheading:2959177-Hypersensitivity, Immediate, pubmed-meshheading:2959177-Male, pubmed-meshheading:2959177-Mice, pubmed-meshheading:2959177-Mice, Inbred Strains, pubmed-meshheading:2959177-Pyrilamine, pubmed-meshheading:2959177-Rats, pubmed-meshheading:2959177-Rats, Inbred Strains, pubmed-meshheading:2959177-Skin, pubmed-meshheading:2959177-Species Specificity, pubmed-meshheading:2959177-Terfenadine
pubmed:year
1987
pubmed:articleTitle
Inhibition of histamine and allergen skin wheal by cetirizine in four animal species.
pubmed:affiliation
Research Centre, UCB Pharmaceutical Sector, Chemin du Foriest, Belgium.
pubmed:publicationType
Journal Article, Comparative Study